GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes

Diabetes

Volumn 56, Issue 6, 2007, Pages 1527-1533

  Mayr, Anja ^a   Schlosser, Michael ^b   Grober, Natalie ^a   Kenk, Heidrun ^b   Ziegler, Anette G ^a   Bonifacio, Ezio ^a,c   Achenbach, Peter ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE AUTOANTIBODY; IODINE 125; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY HISTORY; HUMAN; IMMUNIZATION; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTIBODY AFFINITY; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; EPITOPES; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNIZATION; INFANT, NEWBORN; ISLETS OF LANGERHANS; ISOENZYMES;

EID: 34249665017     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1715     Document Type: Article

References (34)

1. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG: Natural history of type 1 diabetes. Diabetes 54 (Suppl. 1):S25-S31, 2005
2. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468, 1999
3. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E: Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114:589-597, 2004
4. Schlosser M, Koczwara K, Kenk H, Strebelow M, Rjasanowski I, Wassmuth R, Achenbach P, Ziegler AG, Bonifacio E: In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 48:1830-1832, 2005
5. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG: Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140:882-886, 2004
6. Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG: Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392, 2004
7. Hoppu S, Ronkainen MS, Kulmala P, Akerblom HK, Knip M: GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes. Clin Exp Immunol 136:120-128, 2004
8. Ronkainen MS, Hoppu S, Korhonen S, Simell S, Veijola R, Ilonen J, Simell O, Knip M: Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes. Eur J Endocrinol 155:633-642, 2006
9. Sohnlein P, Muller M, Syren K, Hartmann U, Bohm BO, Meinck HM, Knip M, Akerblom HK, Richter W: Epitope spreading and a varying but not disease-specific GAD65 antibody response in type I diabetes: the Childhood Diabetes in Finland Study Group. Diabetologia 43:210-217, 2000
10. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG: Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 49:202-208, 2000
11. Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, Lernmark A: Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 39:1091-1098, 1996
12. Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS: Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 48:922-930, 2005
13. Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, Janka HU, Kastendiek C, Sorger M, Louwen F, Ziegler AG: Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type I diabetes: the German BABYDIAB study. Diabetologia 42:671-677, 1999
14. Kulmala P, Savola K, Reijonen H, Veijola R, Vahasalo P, Karjalainen J, Tuomilehto-Wolf E, Ilonen J, Tuomilehto J, Akerblom HK, Knip M: Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children: Childhood Diabetes in Finland Study Group. Diabetes 49:48-58, 2000
15. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G: Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51:1346-1355, 2002
16. Yu J, Yu L, Bugawan TL, Erlich HA, Barriga K, Hoffman M, Rewers M, Eisenbarth GS: Transient antiislet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors. J Clin Endocrinol Metab 85:2421-2428, 2000
17. Schmid S, Buuck D, Knopff A, Bonifacio E, Ziegler AG: BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with type 1 diabetes by delaying exposure to gluten. Diabetologia 47:1130-1131, 2004
18. Naserke HE, Bonifacio E, Ziegler AG: Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 84:1239-1243, 1999
19. Strebelow M, Schlosser M, Ziegler B, Rjasanowski I, Ziegler M: Karlsburg Type I Diabetes Risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 42:661-670, 1999
20. Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712-720, 2003
21. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560, 1990
22. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF: Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259, 1994
23. Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kampe O, Nilsson T: Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89:557-562, 2004
24. Butler MH, Solimena M, Dirkx R Jr, Hayday A, De Camilli P: Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178:2097-2106, 1993
25. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V, Baekkeskov S: Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595-606, 1994
26. Hampe CS, Kockum I, Landin-Olsson M, Törn C, Örtqvist E, Persson B, Rolandsson O, Palmer J, Lernmark A: GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 25:1481-1482, 2002
27. Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A: Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88:4768-4775, 2003
28. Piquer S, Belloni C, Lampasona V, Bazzigaluppi E, Vianello M, Giometto B, Bosi E, Bottazzo GF, Bonifacio E: Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association. Clin Immunol 117:31-35, 2005
29. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EA, Botazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385-388, 1992
30. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alpe CA, Jackson RA, Eisenbarth GS: Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41:347-353, 1992
31. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK: Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91:350-356, 1993
32. Achenbach P, Warncke K, Reiter J, Williams AJK, Ziegler AG, Bingley PJ, Bonifacio E: Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia 49:2969-2976, 2006
33. Sabbah E, Savola K, Ebeling T, Kumala P, Vahasalo P, Ilonen J, Salela PI, Knip M: Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 23:1326-1332, 2000
34. Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR, Holman RR: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 48:703-708, 2005